Hanna N - Search Results

1

Does the type of first-line regimens influence the receipt of second-line chemotherapy treatment? An analysis of 3211 metastatic colon cancer patients.

Zheng Z, Hanna N, Onukwugha E, Reese ES, Seal B, Mullins CD. Zheng Z, et al. Among authors: hanna n. Cancer Med. 2014 Feb;3(1):124-33. doi: 10.1002/cam4.176. Epub 2014 Jan 7. Cancer Med. 2014. PMID: 24403130 Free PMC article.

2

Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data.

Hanna NN, Onukwugha E, Choti MA, Davidoff AJ, Zuckerman IH, Hsu VD, Mullins CD. Hanna NN, et al. Colorectal Dis. 2012 Jan;14(1):48-55. doi: 10.1111/j.1463-1318.2011.02545.x. Colorectal Dis. 2012. PMID: 21689262

3

Trends in disparities in receipt of adjuvant therapy for elderly stage III colon cancer patients: the role of the medical oncologist evaluation.

Davidoff AJ, Rapp T, Onukwugha E, Zuckerman IH, Hanna N, Pandya N, Mullins CD. Davidoff AJ, et al. Among authors: hanna n. Med Care. 2009 Dec;47(12):1229-36. doi: 10.1097/MLR.0b013e3181b58a85. Med Care. 2009. PMID: 19786906

4

Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients.

Mullins CD, Hsiao FY, Onukwugha E, Pandya NB, Hanna N. Mullins CD, et al. Among authors: hanna n. Cancer. 2012 Jun 15;118(12):3173-81. doi: 10.1002/cncr.26613. Epub 2011 Oct 21. Cancer. 2012. PMID: 22020739 Free article.

5

Algorithm for identifying chemotherapy/biological regimens for metastatic colon cancer in SEER-Medicare.

Bikov KA, Mullins CD, Seal B, Onukwugha E, Hanna N. Bikov KA, et al. Among authors: hanna n. Med Care. 2015 Aug;53(8):e58-64. doi: 10.1097/MLR.0b013e31828fad9f. Med Care. 2015. PMID: 23552436

6

Hospital center effect for laparoscopic colectomy among elderly stage I-III colon cancer patients.

Zheng Z, Hanna N, Onukwugha E, Bikov KA, Mullins CD. Zheng Z, et al. Among authors: hanna n. Ann Surg. 2014 May;259(5):924-9. doi: 10.1097/SLA.0b013e31829d0468. Ann Surg. 2014. PMID: 23817508

7

Clinical and demographic characteristics associated with the receipt of chemotherapy treatment among 7951 elderly metastatic colon cancer patients.

Reese ES, Onukwugha E, Hanna N, Seal BS, Mullins CD. Reese ES, et al. Among authors: hanna n. Cancer Med. 2013 Dec;2(6):907-15. doi: 10.1002/cam4.143. Epub 2013 Oct 10. Cancer Med. 2013. PMID: 24403264 Free PMC article.

8

Cost-effectiveness of second-line chemotherapy/biologics among elderly metastatic colon cancer patients.

Zheng Z, Onukwugha E, Hanna N, Bikov K, Seal B, Mullins CD. Zheng Z, et al. Among authors: hanna n. Adv Ther. 2014 Jul;31(7):724-34. doi: 10.1007/s12325-014-0134-8. Epub 2014 Jul 15. Adv Ther. 2014. PMID: 25022528 Free PMC article.

9

Patterns of Biologics Use Across Treatment Lines in Elderly (Age >65) Medicare Patients With Metastatic Colon Cancer.

Bikov KA, Mullins CD, Hung A, Seal B, Onukwugha E, Hanna N. Bikov KA, et al. Among authors: hanna n. Oncologist. 2016 Jun;21(6):676-83. doi: 10.1634/theoncologist.2015-0199. Epub 2016 Apr 28. Oncologist. 2016. PMID: 27125751 Free PMC article.

10

Sequential Therapies and the Cost-Effectiveness of Treating Metastatic Colon Cancer Patients.

Woldemichael A, Onukwugha E, Seal B, Hanna N, Mullins CD. Woldemichael A, et al. Among authors: hanna n. J Manag Care Spec Pharm. 2016 Jun;22(6):628-39. doi: 10.18553/jmcp.2016.22.6.628. J Manag Care Spec Pharm. 2016. PMID: 27231791 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

806 results

Search Page

Filters